Pharmacare with no new medicines

10 December 2019 - Meeting with pricing officials shows that government's true goal is to slash prices so low that no ...

Read more →

Do large pharma companies provide drug development innovation? Our analysis says no.

10 December 2019 - Large pharmaceutical companies oppose legislation being considered by Congress to lower the prices of prescription drugs. ...

Read more →

Proposed changes to research and development tax incentive will discourage investment and undermine innovation

6 December 2019 - Medicines Australia is disappointed that proposed changes to the Research and Development Tax Incentive were tabled ...

Read more →

White House claims Speaker Nancy Pelosi’s drug pricing bill would result in 100 fewer drugs over a decade

3 December 2019 - The report from the administration suggests far greater consequences for both the drug industry and American consumers ...

Read more →

Using GRADE methodology to assess innovation of new medicinal products in Italy

25 November 2019 - In April 2017 the Italian Medicine Agency developed new criteria to grant any new medicinal product with ...

Read more →

Pelosi’s drug pricing plan puts medical innovation at risk

17 October 2019 - The future of medical innovation in America is at a crossroads. ...

Read more →

Intellectual property law amends will add to business uncertainty

26 July 2019 - Medicines Australia supports efforts to strengthen Australia’s Intellectual Property arrangements to be consistent with international best ...

Read more →

Government to invest £16 million in 'life-saving' medical advances

22 July 2019 - The Government has announced the decision to invest around £16 million in various ‘life-saving’ medical advances, ...

Read more →

How the FDA uses science to speed medical device innovation

11 July 2019 - The MDDT program streamlines the medical device development and review process. ...

Read more →

GSK welcomes the UK trial of subscription-style payment system for pharma companies to incentivise creation of new antibiotics

9 July 2019 - GSK is committed to tackling antimicrobial resistance as part of a sustained, multi-stakeholder response to this global ...

Read more →

UK launches subscription style payment pilot to incentivise pharma antibiotics R&D

9 July 2019 - The UK is to try out a subscription-style payment model aimed at incentivising pharma and biotech ...

Read more →

Innovation prizes to support cell and gene therapy

2 July 2019 - Personalised cell and gene therapy represent a fundamental therapeutic revolution.  ...

Read more →

Rebalancing high prescription drug prices with innovation incentive

1 July 2019 - The current firestorm over high drug prices didn’t start with the May 2019 approval of Novartis’s onasemnogene ...

Read more →

Azar's plan to tie U.S. drug prices to foreign ones will impact investments in R&D

21 June 2019 - Americans, be they Republicans or Democrats, are outraged by the rising cost of prescription drugs.  ...

Read more →

Sustainable discovery and development of antibiotics — is a non-profit approach the future?

19 June 2019 - Shifting to a nonprofit-driven model for development of antibiotics could encourage discovery and development of truly needed ...

Read more →